Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AVTE | Aerovate Therapeutics, Inc. | Director | $205K | Jun 5, 2024 | ||
SRZN, SRZNW | Surrozen, Inc./DE | Former Director | $11.4K | Aug 11, 2021 | ||
OYST | Oyster Point Pharma, Inc. | Director | Jan 3, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|